ClinicalTrials.gg
RecruitingNCT05453019Updated Jun 6, 2023

Effects of CI on Tinnitus and Its Symptoms

An interventional study of Cochlear Implant in Tinnitus, sponsored by Chinese PLA General Hospital. Recruiting at 1 site in China. Open to participants aged 16 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-06-06.

Sponsored by Chinese PLA General Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jul 2022; still recruiting 4 years 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Non-randomized
Ages
16 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 32 studies in Tinnitus with a site in China — 18 open to participants now, 18 under way, none of them phase 3. Tinnitus · China.

Planned enrollment
7th of 27
200 · median 120
Started
2022
with 4 others
No phase
27 of 32
16 open now
Primary completion
2027-07
later than 10 of 17 live
Registered
7th of 32
by date
Lead sponsor
1 of 32
Chinese PLA General Hospital

Among the 32 studies in Tinnitus with a site in China, this one is the 7th largest by planned enrollment of the 27 interventional ones that give a count, is one of 5 that started in 2022, is one of 27 with no phase, reaches primary completion later than 10 of the 17 other live ones, and was the 7th registered.

Tinnitus

446 studies on the registry are indexed under Tinnitus; 98 are open to participants now.

Browse Tinnitus studies →

Open to participants now

18 of the 32 studies in Tinnitus with a site in China are open now. Recruiting first, the newest first:

12 more — sign in →

All 18 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 49 Tinnitus studies recruiting now, 21 (43%) set no upper age limit and 18 (37%) stop at 75 or younger; 4 take children under 18; 10 take healthy volunteers.

This study: 16 Years to 90 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 32 studies in Tinnitus with a site in China, or all of them as a file.
02

Study summary

Abnormal activity in the central auditory system is the cause of subjective experience of tinnitus. Electrical stimulation can inhibit the abnormal activity of auditory related neurons in patients with tinnitus. In recent years, the application of electrical stimulation in the treatment of tinnitus is a hot research topic, and has made some progress. However, its treatment is still in the discussion stage, and there is no best scheme suitable for clinical practice. At present, scholars have found that cochlear electrode stimulation can inhibit tinnitus, but its mechanism is not clear. It is difficult to locate the origin of tinnitus, and the location of electrode stimulation and stimulation parameters still need to be further optimized. Because the implanted part of the cochlear implant contains magnets, the patients cannot perform functional MRI. However, the prevalence of tinnitus in this group is very high (67.0\~100.0%, with an average of 80.0%), so it is of great value and significance to study the effect of tinnitus treatment in such patients. In this study, a new clinical electroencephalogram (EEG) technique was used to make up for the lack of MRI imaging in patients with electrode implantation. EEG analyzes the functional connection of different brain regions through EEG test electrodes, uses the traceability function of EEG software to locate the location of tinnitus, analyzes the process of tinnitus inhibition by electrical stimulation, and explains the mechanism of tinnitus inhibition by electrical stimulation from a new perspective.

Read the detailed description
  1. Research content 1.1 Study on the change law of tinnitus affected by electrical stimulation after electrode implantation: 1) The change of tinnitus before operation after cochlear implantation; 2) Long term observation of electrical stimulation after cochlear implantation: (1) The change rule of tinnitus loudness after electrical stimulation (how long can it recover to be stable after power on); (2) The regularity of tinnitus frequency after electrical stimulation; (3) The recovery of tinnitus after electrode implantation for various causes of deafness.

    1.2 Study on the mechanism of electric stimulation inhibiting tinnitus: 1) Changes of resting EEG in patients with tinnitus before surgery, before surgery-after surgery, 1 month, 2 months, 3 months, 6 months, 12 month, more than 12 months; 2) The compilation of resting electroencephalogram analysis program; 3) The resting brain wave shape was analyzed to trace the anatomical position of the artificial cochlea to inhibit tinnitus.

    1.3 Study on the optimal setting of electrode stimulation for tinnitus treatment: 1) Setting different electric stimulation frequency and stimulation rate parameters to mask tinnitus; 2) Set the procedure of electric stimulation cochlear implant to mask tinnitus.

  2. Research objectives 1) Summarize the changes of tinnitus after electrode implantation (effective treatment time, diseases suitable for electrical stimulation treatment, etc.); 2) Infer the mechanism of electric stimulation inhibiting tinnitus; 3) Set electrical stimulation parameters to effectively suppress tinnitus.
  3. Scientific problems to be solved Our study group plan to use more advanced EEG technology to explore the principle of electric stimulation to suppress tinnitus, find out the effective scheme of electric stimulation to treat tinnitus, and help more patients solve the problem of tinnitus.
03

Conditions studied

  • Tinnitus

Browse trials for

Keywords

  • tinnitus
  • electrical stimulation
  • cochlear implant
04

Who can participate

Ages eligible
16 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    1. This study included patients who received cochlear implants at the Auditory Implant Center of the Otorhinolaryngology-Head and Neck Surgery, China PLA General Hospital;
    1. The patients ranged from 16 to 90 years old;
    1. The patient experienced hearing loss and had either tinnitus longer than 0.25 years (experimental group 1) or no tinnitus (control group 2) before the cochlear implant surgery;
    1. The cochlear implants accepted by patients included products from MED-EL, Cochlear, Advanced Bionics and Nurotron;
    1. All patients voluntarily participated in the study.

Exclusion criteria

Exclusion Criteria:

  • 1 Tinnitus types exclude non otogenic tinnitus (including tinnitus caused by hypertension, heart disease, hyperthyroidism, neurasthenia, hyperlipidemia, etc.);
  • 2 of cochlear implant surgery (refer to the guidelines for cochlear implant 2013 of the Chinese Medical Association);
  • 3 Intellectual deficiency
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    tinnitus group

    Patients who have tinnitus got cochlear implant

    Device: Cochlear Implant

  • Active comparator
    without tinnitus group

    Patients who have no tinnitus got cochlear implant

    Device: Cochlear Implant

Interventions

  • DeviceCochlear Implant

    The surgeon will make a small cut (incision) behind patient's ear, and form a small hole in the portion of skull bone (mastoid) where the internal device rests. Then the surgeon create a small opening in the cochlea in order to thread the electrode of the internal cochlear implant device. The skin incision is stitched closed so that the internal device is under the skin.

06

What researchers measure

Primary outcomes

  1. Electrical stimulation channel number

    Stimulating basement membrane with cochlear implant electrode to match tinnitus frequency. The cochlear implant electrode number is recorded.

    Time frame: 1 week after operation

  2. Electrical stimulation channel number

    frequency. The cochlear implant electrode number is recorded.

    Time frame: 1 month after operation

  3. Electrical stimulation channel number

    frequency. The cochlear implant electrode number is recorded.

    Time frame: 2 months after operation

  4. Electrical stimulation channel number

    frequency. The cochlear implant electrode number is recorded.

    Time frame: 3 months after CI operation

  5. Electrical stimulation channel number

    frequency. The cochlear implant electrode number is recorded.

    Time frame: 4 months after operation

  6. Electrical stimulation channel number

    frequency. The cochlear implant electrode number is recorded.

    Time frame: 7 months after operation

  7. Electrical stimulation channel number

    frequency. The cochlear implant electrode number is recorded.

    Time frame: 13 months after operation

  8. Electrical stimulation channel number

    frequency. The cochlear implant electrode number is recorded.

    Time frame: over 13 months after operation

  9. Tinnitus characteristic information questionnaire

    A multifactorial and closed-ended questionnaire was developed by our CI center. The demographics and part of the tinnitus descriptions were recorded in Tinnitus Characteristics questionnaire for CI recipients. The patients' basic information, such as gender, age, aetiology, CI side, CI type, and time of deafness was completed by patients. Tinnitus characteristics information, including localization, duration, and type was collected for correlation analysis.

    Time frame: Pre-operation

  10. Tinnitus characteristic information questionnaire

    A multifactorial and closed-ended questionnaire was developed by our CI center. The demographics and part of the tinnitus descriptions were recorded in Tinnitus Characteristics questionnaire for CI recipients. The patients' basic information, such as gender, age, aetiology, CI side, CI type, and time of deafness was completed by patients. Tinnitus characteristics information, including localization, duration, and type was collected for correlation analysis.

    Time frame: 1 week after operation

  11. Tinnitus characteristic information questionnaire

    A multifactorial and closed-ended questionnaire was developed by our CI center. The demographics and part of the tinnitus descriptions were recorded in Tinnitus Characteristics questionnaire for CI recipients. The patients' basic information, such as gender, age, aetiology, CI side, CI type, and time of deafness was completed by patients. Tinnitus characteristics information, including localization, duration, and type was collected for correlation analysis.

    Time frame: 1 month after operation

  12. Tinnitus characteristic information questionnaire

    A multifactorial and closed-ended questionnaire was developed by our CI center. The demographics and part of the tinnitus descriptions were recorded in Tinnitus Characteristics questionnaire for CI recipients. The patients' basic information, such as gender, age, aetiology, CI side, CI type, and time of deafness was completed by patients. Tinnitus characteristics information, including localization, duration, and type was collected for correlation analysis.

    Time frame: 2 months after operation

  13. Tinnitus characteristic information questionnaire

    A multifactorial and closed-ended questionnaire was developed by our CI center. The demographics and part of the tinnitus descriptions were recorded in Tinnitus Characteristics questionnaire for CI recipients. The patients' basic information, such as gender, age, aetiology, CI side, CI type, and time of deafness was completed by patients. Tinnitus characteristics information, including localization, duration, and type was collected for correlation analysis.

    Time frame: 3 months after operation

  14. Tinnitus characteristic information questionnaire

    A multifactorial and closed-ended questionnaire was developed by our CI center. The demographics and part of the tinnitus descriptions were recorded in Tinnitus Characteristics questionnaire for CI recipients. The patients' basic information, such as gender, age, aetiology, CI side, CI type, and time of deafness was completed by patients. Tinnitus characteristics information, including localization, duration, and type was collected for correlation analysis.

    Time frame: 4 months after operation

  15. Tinnitus characteristic information questionnaire

    A multifactorial and closed-ended questionnaire was developed by our CI center. The demographics and part of the tinnitus descriptions were recorded in Tinnitus Characteristics questionnaire for CI recipients. The patients' basic information, such as gender, age, aetiology, CI side, CI type, and time of deafness was completed by patients. Tinnitus characteristics information, including localization, duration, and type was collected for correlation analysis.

    Time frame: 7 months after operation

  16. Tinnitus characteristic information questionnaire

    A multifactorial and closed-ended questionnaire was developed by our CI center. The demographics and part of the tinnitus descriptions were recorded in Tinnitus Characteristics questionnaire for CI recipients. The patients' basic information, such as gender, age, aetiology, CI side, CI type, and time of deafness was completed by patients. Tinnitus characteristics information, including localization, duration, and type was collected for correlation analysis.

    Time frame: 13 months after operation

  17. Tinnitus characteristic information questionnaire

    A multifactorial and closed-ended questionnaire was developed by our CI center. The demographics and part of the tinnitus descriptions were recorded in Tinnitus Characteristics questionnaire for CI recipients. The patients' basic information, such as gender, age, aetiology, CI side, CI type, and time of deafness was completed by patients. Tinnitus characteristics information, including localization, duration, and type was collected for correlation analysis.

    Time frame: over 13 months after operation

  18. Tinnitus loudness(CI electrical stimulation intensity)

    The tinnitus loudness was matched by the stimulation current level of cochlear implant electrode, The ultimate electrode stimulation current (IµA) is quantified in µA and the tinnitus loudness is recorded in Qtin (nC, 10-9C) (i.e. Qtin=IµA\* tp).

    Time frame: 1 week after operation

  19. Tinnitus loudness(CI electrical stimulation intensity)

    The tinnitus loudness was matched by the stimulation current level of cochlear implant electrode, The ultimate electrode stimulation current (IµA) is quantified in µA and the tinnitus loudness is recorded in Qtin (nC, 10-9C) (i.e. Qtin=IµA\* tp).

    Time frame: 1 month after operation

  20. Tinnitus loudness(CI electrical stimulation intensity)

    The tinnitus loudness was matched by the stimulation current level of cochlear implant electrode, The ultimate electrode stimulation current (IµA) is quantified in µA and the tinnitus loudness is recorded in Qtin (nC, 10-9C) (i.e. Qtin=IµA\* tp).

    Time frame: 2 months after operation

  21. Tinnitus loudness(CI electrical stimulation intensity)

    The tinnitus loudness was matched by the stimulation current level of cochlear implant electrode, The ultimate electrode stimulation current (IµA) is quantified in µA and the tinnitus loudness is recorded in Qtin (nC, 10-9C) (i.e. Qtin=IµA\* tp).

    Time frame: 3 months after operation

  22. Tinnitus loudness(CI electrical stimulation intensity)

    The tinnitus loudness was matched by the stimulation current level of cochlear implant electrode, The ultimate electrode stimulation current (IµA) is quantified in µA and the tinnitus loudness is recorded in Qtin (nC, 10-9C) (i.e. Qtin=IµA\* tp).

    Time frame: 4 months after operation

  23. Tinnitus loudness(CI electrical stimulation intensity)

    The tinnitus loudness was matched by the stimulation current level of cochlear implant electrode, The ultimate electrode stimulation current (IµA) is quantified in µA and the tinnitus loudness is recorded in Qtin (nC, 10-9C) (i.e. Qtin=IµA\* tp).

    Time frame: 7 months after operation

  24. Tinnitus loudness(CI electrical stimulation intensity)

    The tinnitus loudness was matched by the stimulation current level of cochlear implant electrode, The ultimate electrode stimulation current (IµA) is quantified in µA and the tinnitus loudness is recorded in Qtin (nC, 10-9C) (i.e. Qtin=IµA\* tp).

    Time frame: 13 months after operation

  25. Tinnitus loudness(CI electrical stimulation intensity)

    The tinnitus loudness was matched by the stimulation current level of cochlear implant electrode, The ultimate electrode stimulation current (IµA) is quantified in µA and the tinnitus loudness is recorded in Qtin (nC, 10-9C) (i.e. Qtin=IµA\* tp).

    Time frame: over 13 months after operation

  26. Objective electroencephalography-based assessment(EEG)

    EEG is a non-invasive objective assessment technique that records brain activity along with specific neural pathways. we utilize cortical auditory evoked potential (CAEP) and event-related potentials(ERP) to obtain time-domain analysis.

    Time frame: Pre-operation

  27. Objective electroencephalography-based assessment(EEG)

    The EEG waveforms of CI patients were tested, and the amplitude and latency were recorded.

    Time frame: 1 week after operation

  28. Objective electroencephalography-based assessment(EEG)

    EEG is a non-invasive objective assessment technique that records brain activity along with specific neural pathways. we utilize cortical auditory evoked potential (CAEP) and event-related potentials(ERP) to obtain time-domain analysis.

    Time frame: 1 month after operation

  29. Objective electroencephalography-based assessment(EEG)

    EEG is a non-invasive objective assessment technique that records brain activity along with specific neural pathways. we utilize cortical auditory evoked potential (CAEP) and event-related potentials(ERP) to obtain time-domain analysis.

    Time frame: 2 months after operation

  30. Objective electroencephalography-based assessment(EEG)

    EEG is a non-invasive objective assessment technique that records brain activity along with specific neural pathways. we utilize cortical auditory evoked potential (CAEP) and event-related potentials(ERP) to obtain time-domain analysis.

    Time frame: 3 months after operation

  31. Objective electroencephalography-based assessment(EEG)

    EEG is a non-invasive objective assessment technique that records brain activity along with specific neural pathways. we utilize cortical auditory evoked potential (CAEP) and event-related potentials(ERP) to obtain time-domain analysis.

    Time frame: 4 months after operation

  32. Objective electroencephalography-based assessment(EEG)

    EEG is a non-invasive objective assessment technique that records brain activity along with specific neural pathways. we utilize cortical auditory evoked potential (CAEP) and event-related potentials(ERP) to obtain time-domain analysis.

    Time frame: 7 months after operation

  33. Objective electroencephalography-based assessment(EEG)

    EEG is a non-invasive objective assessment technique that records brain activity along with specific neural pathways. we utilize cortical auditory evoked potential (CAEP) and event-related potentials(ERP) to obtain time-domain analysis.

    Time frame: 13 months after operation

  34. Objective electroencephalography-based assessment(EEG)

    EEG is a non-invasive objective assessment technique that records brain activity along with specific neural pathways. we utilize cortical auditory evoked potential (CAEP) and event-related potentials(ERP) to obtain time-domain analysis.

    Time frame: over 13 months after operation

  35. Speech perception

    The patient are tested for speech recognition and the results were recorded as a percentage

    Time frame: Pre-operation

  36. Speech perception

    The patient are tested for speech recognition and the results were recorded as a percentage

    Time frame: 1 months after operation

  37. Speech perception

    The patient are tested for speech recognition and the results were recorded as a percentage

    Time frame: 2 month after operation

  38. Speech perception

    The patient are tested for speech recognition and the results were recorded as a percentage

    Time frame: 4 months after operation

  39. Speech perception

    The patient are tested for speech recognition and the results were recorded as a percentage

    Time frame: 7 months after operation

  40. Speech perception

    The patient are tested for speech recognition and the results were recorded as a percentage

    Time frame: 13 months after CI operation

  41. Speech perception

    The patient are tested for speech recognition and the results were recorded as a percentage

    Time frame: over 13 months after CI activation

Secondary outcomes

  1. Pure tone test

    Evaluation of 250-8000hz hearing effect in patients with hearing loss

    Time frame: pre-operation

  2. Pure tone test

    Evaluation of 250-8000hz hearing effect in patients with hearing loss

    Time frame: 1 month after operation

  3. Pure tone test

    Evaluation of 250-8000hz hearing effect in patients with hearing loss

    Time frame: 2 months after operation

  4. Pure tone test

    Evaluation of 250-8000hz hearing effect in patients with hearing loss

    Time frame: 4 months after operation

  5. Pure tone test

    Evaluation of 250-8000hz hearing effect in patients with hearing loss

    Time frame: 7 month after operation

  6. Pure tone test

    Evaluation of 250-8000hz hearing effect in patients with hearing loss

    Time frame: 13 month after operation

  7. Pure tone test

    Evaluation of 250-8000hz hearing effect in patients with hearing loss

    Time frame: over 13 month after operation

  8. Self-Rating Anxiety Scale (SAS) questionnaire

    Assessment of patients' mental state (depression, anxiety, insomnia),The result analysis chart of this system shows the standard score. The higher the score, the more serious the symptoms in this regard. Generally speaking, those whose total anxiety score is less than 50 are normal; 50-60 is mild, 61-70 is moderate, and more than 70 is severe anxiety. The number of negative items means the number of items on which the subject did not respond, and the number of positive items means the number of items on which the subject responded. Total rough score: the scores of 20 items are added together, and the demarcation score is 40 points.

    Time frame: Pre-operation

  9. Self-Rating Anxiety Scale (SAS) questionnaire

    Assessment of patients' mental state (depression, anxiety, insomnia),The result analysis chart of this system shows the standard score. The higher the score, the more serious the symptoms in this regard. Generally speaking, those whose total anxiety score is less than 50 are normal; 50-60 is mild, 61-70 is moderate, and more than 70 is severe anxiety. The number of negative items means the number of items on which the subject did not respond, and the number of positive items means the number of items on which the subject responded. Total rough score: the scores of 20 items are added together, and the demarcation score is 40 points.

    Time frame: 1 month after operation

  10. Self-Rating Anxiety Scale (SAS) questionnaire

    Assessment of patients' mental state (depression, anxiety, insomnia),The result analysis chart of this system shows the standard score. The higher the score, the more serious the symptoms in this regard. Generally speaking, those whose total anxiety score is less than 50 are normal; 50-60 is mild, 61-70 is moderate, and more than 70 is severe anxiety. The number of negative items means the number of items on which the subject did not respond, and the number of positive items means the number of items on which the subject responded. Total rough score: the scores of 20 items are added together, and the demarcation score is 40 points.

    Time frame: 2 months after operation

  11. Self-Rating Anxiety Scale (SAS) questionnaire

    Assessment of patients' mental state (depression, anxiety, insomnia),The result analysis chart of this system shows the standard score. The higher the score, the more serious the symptoms in this regard. Generally speaking, those whose total anxiety score is less than 50 are normal; 50-60 is mild, 61-70 is moderate, and more than 70 is severe anxiety. The number of negative items means the number of items on which the subject did not respond, and the number of positive items means the number of items on which the subject responded. Total rough score: the scores of 20 items are added together, and the demarcation score is 40 points.

    Time frame: 4 months after operation

  12. Self-Rating Anxiety Scale (SAS) questionnaire

    Assessment of patients' mental state (depression, anxiety, insomnia),The result analysis chart of this system shows the standard score. The higher the score, the more serious the symptoms in this regard. Generally speaking, those whose total anxiety score is less than 50 are normal; 50-60 is mild, 61-70 is moderate, and more than 70 is severe anxiety. The number of negative items means the number of items on which the subject did not respond, and the number of positive items means the number of items on which the subject responded. Total rough score: the scores of 20 items are added together, and the demarcation score is 40 points.

    Time frame: 7 months after operation

  13. Self-Rating Anxiety Scale (SAS) questionnaire

    Assessment of patients' mental state (depression, anxiety, insomnia),The result analysis chart of this system shows the standard score. The higher the score, the more serious the symptoms in this regard. Generally speaking, those whose total anxiety score is less than 50 are normal; 50-60 is mild, 61-70 is moderate, and more than 70 is severe anxiety. The number of negative items means the number of items on which the subject did not respond, and the number of positive items means the number of items on which the subject responded. Total rough score: the scores of 20 items are added together, and the demarcation score is 40 points.

    Time frame: 13 months after operation

  14. Self-Rating Anxiety Scale (SAS) questionnaire

    Assessment of patients' mental state (depression, anxiety, insomnia),The result analysis chart of this system shows the standard score. The higher the score, the more serious the symptoms in this regard. Generally speaking, those whose total anxiety score is less than 50 are normal; 50-60 is mild, 61-70 is moderate, and more than 70 is severe anxiety. The number of negative items means the number of items on which the subject did not respond, and the number of positive items means the number of items on which the subject responded. Total rough score: the scores of 20 items are added together, and the demarcation score is 40 points.

    Time frame: over 13 months after operation

07

Study locations

1 of 1 sites recruiting
  • Qian Wang
    Beijing, France 100085, China
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2022 (actual). Primary completion is estimated for Jul 2027, 59 months after the start.

Of 134 non-industry interventional studies with no phase under Tinnitus, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 38. This study's planned 59 months is above that.

Counting every sponsor, half of 153 studies reached it within 17 months; a quarter within 10 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 22, 2022
First posted
Jul 12, 2022
StartActual
Jul 4, 2022
Primary completionEst.
Jul 1, 2027
CompletionEst.
Jul 1, 2027
Last update
Jun 6, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05453019
Responsible party
YangShiming (Professor, Chinese PLA General Hospital) — Principal investigator
First posted
Jul 12, 2022
Start date
Jul 4, 2022
Primary completion
Jul 1, 2027 (estimated)
Completion
Jul 1, 2027 (estimated)
Last update
Jun 6, 2023

Study contacts

QIAN WANG, M.S.
Contact
only_elizabeth@126.com
+8618211068103
Shi m Yang
Contact
yangsm301@263.net
01068159050
Shi m Yang, M.D., Ph.D.
study director · Chinese PLA General Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion